7-94429311-A-G
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 3P and 1B. PM1PP2BP4
The NM_000089.4(COL1A2):c.3835A>G(p.Met1279Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000217 in 1,614,032 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M1279L) has been classified as Uncertain significance.
Frequency
Consequence
NM_000089.4 missense
Scores
Clinical Significance
Conservation
Publications
- Ehlers-Danlos syndrome, arthrochalasia type, 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Illumina, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- osteogenesis imperfectaInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- osteogenesis imperfecta type 1Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- osteogenesis imperfecta type 2Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen
- osteogenesis imperfecta type 3Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
- osteogenesis imperfecta type 4Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- Ehlers-Danlos syndrome, arthrochalasia typeInheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
- Ehlers-Danlos syndrome, cardiac valvular typeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, ClinGen, PanelApp Australia, Orphanet, G2P
- combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2Inheritance: AD Classification: MODERATE Submitted by: ClinGen, Ambry Genetics
- Ehlers-Danlos/osteogenesis imperfecta syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- high bone mass osteogenesis imperfectaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000089.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| COL1A2 | NM_000089.4 | MANE Select | c.3835A>G | p.Met1279Val | missense | Exon 51 of 52 | NP_000080.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| COL1A2 | ENST00000297268.11 | TSL:1 MANE Select | c.3835A>G | p.Met1279Val | missense | Exon 51 of 52 | ENSP00000297268.6 | ||
| COL1A2 | ENST00000464916.1 | TSL:2 | n.883A>G | non_coding_transcript_exon | Exon 3 of 4 | ||||
| COL1A2 | ENST00000481570.5 | TSL:2 | n.4616A>G | non_coding_transcript_exon | Exon 8 of 8 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152072Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000757 AC: 19AN: 251018 AF XY: 0.0000442 show subpopulations
GnomAD4 exome AF: 0.0000192 AC: 28AN: 1461842Hom.: 0 Cov.: 33 AF XY: 0.0000151 AC XY: 11AN XY: 727216 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152190Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74402 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant summary: COL1A2 c.3835A>G (p.Met1279Val) results in a conservative amino acid change in the encoded protein sequence. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change. The variant allele was found at a frequency of 7.6e-05 in 251018 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in COL1A2 causing Ehlers-Danlos syndrome, cardiac valvular type (7.6e-05 vs 0.0011), allowing no conclusion about variant significance. c.3835A>G has been observed in individual(s) with clinical features of COL1A2-related conditions (Internal data). These report(s) do not provide unequivocal conclusions about association of the variant with Ehlers-Danlos syndrome, cardiac valvular type. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. ClinVar contains an entry for this variant (Variation ID: 579441). Based on the evidence outlined above, the variant was classified as uncertain significance.
not provided Uncertain:1
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge
Osteogenesis imperfecta type I;C0268335:Ehlers-Danlos syndrome, classic type, 1 Uncertain:1
This sequence change replaces methionine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 1279 of the COL1A2 protein (p.Met1279Val). This variant is present in population databases (rs775850964, gnomAD 0.04%). This missense change has been observed in individual(s) with clinical features of COL1A2-related conditions (internal data). ClinVar contains an entry for this variant (Variation ID: 579441). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt COL1A2 protein function with a positive predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at